Therapeutic Antibodies – News and Features
News
PDL Grants Patent Licenses to Merck for Humanized Antibodies
The licensing of humanized antibody technology will build a commercial operation focused on the acute care hospital setting.
News
Morphotek Expands Oncology Pipeline with Product Candidate from NCI
Morphotek is applying its antibody technologies to develop and optimize antibodies to cancer-associated proteins.
News
Acceptys and OncoMab Announce Integration of Human Antibody Drug Development Pipeline and Operations
Acceptys has acquired the right to develop all 8 lead antibody therapeutic candidates from the OncoMab pipeline.
News
Antibody Therapy Promising for Pediatric Neuroblastoma
Study suggests that the immune system can be manipulated to target cancer cells, resistant to chemotherapy.
News
MorphoSys Signs Agreement for Use of Antibody Technologies with Merck & Co.
The agreement enables Merck to develop HuCAL®-derived therapeutic antibodies in a range of indications.
News
MorphoSys Announces Extension of Antibody Collaboration with Bayer
MorphoSys grants Bayer access to its proprietary HuCAL GOLD® antibody library.
News
MedImmune Licenses BioWa’s POTELLIGENT™ Technology
BioWa will provide MedImmune with commercial rights to use the technology to enhance antibody-dependent cellular cytotoxicity.
News
Domantis Announces Therapeutic Alliance with Bristol-Myers Squibb
Both companies collaborate to develop domain antibody products.
News
Alder Biopharmaceuticals Forms Collaboration with Schering-Plough
The collaboration will use Alder's antibody selection system to identify and produce antibodies.
News
Avid Bioservices Announces Bioproduction Contract with Major Leading Cancer Center
Avid Bioservices will manage process development and cGMP manufacturing for drug candidate.
Advertisement
